Bicara Therapeutics Inc.
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
BCAX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 116 HUNTINGTON AVENUE SUITE 703, 2116 BOSTON
- Website:
- https://www.bicara.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class bifunctional therapies for patients with solid tumors. The company engineers advanced biologics designed to combine the precision of a validated tumor-targeting agent with the power of a tumor microenvironment modulator. This dual-action approach aims to deliver more effective and durable anti-tumor responses. Bicara's pipeline is dedicated to advancing these innovative targeted treatments to address significant unmet needs in oncology, with a focus on indications such as head and neck cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Bicara Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bicara Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bicara Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
